Liu, J.; Zeng, X.; Lin, Y.-Q.; Peng, Y.-S.; Liu, L.; Chen, S.-H.; Du, Y.-H.
The Marine Compound Isaridin E Ameliorates Lipopolysaccharide-Induced Vascular Endothelial Inflammation via the Downregulation of the TLR4/NF-κB Signaling Pathway. Mar. Drugs 2025, 23, 145.
https://doi.org/10.3390/md23040145
AMA Style
Liu J, Zeng X, Lin Y-Q, Peng Y-S, Liu L, Chen S-H, Du Y-H.
The Marine Compound Isaridin E Ameliorates Lipopolysaccharide-Induced Vascular Endothelial Inflammation via the Downregulation of the TLR4/NF-κB Signaling Pathway. Marine Drugs. 2025; 23(4):145.
https://doi.org/10.3390/md23040145
Chicago/Turabian Style
Liu, Jing, Xin Zeng, Yu-Quan Lin, Yu-Sheng Peng, Lan Liu, Sen-Hua Chen, and Yan-Hua Du.
2025. "The Marine Compound Isaridin E Ameliorates Lipopolysaccharide-Induced Vascular Endothelial Inflammation via the Downregulation of the TLR4/NF-κB Signaling Pathway" Marine Drugs 23, no. 4: 145.
https://doi.org/10.3390/md23040145
APA Style
Liu, J., Zeng, X., Lin, Y.-Q., Peng, Y.-S., Liu, L., Chen, S.-H., & Du, Y.-H.
(2025). The Marine Compound Isaridin E Ameliorates Lipopolysaccharide-Induced Vascular Endothelial Inflammation via the Downregulation of the TLR4/NF-κB Signaling Pathway. Marine Drugs, 23(4), 145.
https://doi.org/10.3390/md23040145
